| Dr John W Rhee, MD | |
|
1625 N George Mason Dr, Suite 288, Arlington, VA 22205-3683 | |
| (703) 558-6491 | |
| (703) 524-4365 |
| Full Name | Dr John W Rhee |
|---|---|
| Gender | Male |
| Speciality | Cardiac Surgery |
| Experience | 40 Years |
| Location | 1625 N George Mason Dr, Arlington, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073572285 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208G00000X | Thoracic Surgery (cardiothoracic Vascular Surgery) | 0101052255 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Virginia Hospital Center | Arlington, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Virginia Hospital Center Physician Group Llc | 8426231119 | 241 |
News Archive
Compressus, a transformational leader in interoperability and workflow solutions for the rapidly growing healthcare IT market, today announced the integration of M*Modal's Speech Understanding technology with the MEDxConnect suite of healthcare interoperability and workflow solutions from Compressus.
Researchers from the University of British Columbia and the Central South University in China have for the first time identified a gene that increases the risk of Alzheimer's disease.
A new, updated risk score can help predict possible contrast-associated acute kidney injury (CA-AKI) among patients undergoing percutaneous coronary intervention (PCI), Mount Sinai researchers report.
ID Biomedical Corporation announced today that it has been advised by the United States Food and Drug Administration's Center for Biologics Evaluation and Research (CBER) that the Company's injectable influenza vaccine is eligible for accelerated approval and priority review mechanisms, allowing possible licensure of the vaccine in time to manufacture product for the 2006/07 season.
A Lancet World Report examines the details of the Canadian government's strategy for the G8 maternal and child health initiative and reactions from global health leaders and politicians to the plan, including the announcement during a meeting of G8 leaders Halifax, Nova Scotia, that the initiative would not support abortion.
› Verified 7 days ago
| Entity Name | Virginia Hospital Center Physician Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144415480 PECOS PAC ID: 8426231119 Enrollment ID: O20110317000305 |
News Archive
Compressus, a transformational leader in interoperability and workflow solutions for the rapidly growing healthcare IT market, today announced the integration of M*Modal's Speech Understanding technology with the MEDxConnect suite of healthcare interoperability and workflow solutions from Compressus.
Researchers from the University of British Columbia and the Central South University in China have for the first time identified a gene that increases the risk of Alzheimer's disease.
A new, updated risk score can help predict possible contrast-associated acute kidney injury (CA-AKI) among patients undergoing percutaneous coronary intervention (PCI), Mount Sinai researchers report.
ID Biomedical Corporation announced today that it has been advised by the United States Food and Drug Administration's Center for Biologics Evaluation and Research (CBER) that the Company's injectable influenza vaccine is eligible for accelerated approval and priority review mechanisms, allowing possible licensure of the vaccine in time to manufacture product for the 2006/07 season.
A Lancet World Report examines the details of the Canadian government's strategy for the G8 maternal and child health initiative and reactions from global health leaders and politicians to the plan, including the announcement during a meeting of G8 leaders Halifax, Nova Scotia, that the initiative would not support abortion.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr John W Rhee, MD 1625 N George Mason Dr, Suite 288, Arlington, VA 22205-3683 Ph: (703) 558-6491 | Dr John W Rhee, MD 1625 N George Mason Dr, Suite 288, Arlington, VA 22205-3683 Ph: (703) 558-6491 |
News Archive
Compressus, a transformational leader in interoperability and workflow solutions for the rapidly growing healthcare IT market, today announced the integration of M*Modal's Speech Understanding technology with the MEDxConnect suite of healthcare interoperability and workflow solutions from Compressus.
Researchers from the University of British Columbia and the Central South University in China have for the first time identified a gene that increases the risk of Alzheimer's disease.
A new, updated risk score can help predict possible contrast-associated acute kidney injury (CA-AKI) among patients undergoing percutaneous coronary intervention (PCI), Mount Sinai researchers report.
ID Biomedical Corporation announced today that it has been advised by the United States Food and Drug Administration's Center for Biologics Evaluation and Research (CBER) that the Company's injectable influenza vaccine is eligible for accelerated approval and priority review mechanisms, allowing possible licensure of the vaccine in time to manufacture product for the 2006/07 season.
A Lancet World Report examines the details of the Canadian government's strategy for the G8 maternal and child health initiative and reactions from global health leaders and politicians to the plan, including the announcement during a meeting of G8 leaders Halifax, Nova Scotia, that the initiative would not support abortion.
› Verified 7 days ago
Dr. John R Garrett, M.D. Thoracic Surgery (Cardiothoracic Vascular Surgery) Medicare: Accepting Medicare Assignments Practice Location: 1625 N George Mason Dr Ste 288, Arlington, VA 22205 Phone: 703-558-6491 Fax: 703-524-4365 |